雅虎香港 搜尋

搜尋結果

  1. 2020年5月29日 · BALTIMORE, MD / ACCESSWIRE, May 29, 2020 - (ACN Newswire) - Paice and Daimler have reached an agreement to license patented hybrid technology. Paice was an early leader in electrified vehicles. The company was awarded its first hybrid vehicle patent in 1994, long before most automakers began seriously focusing on ways to improve fuel ...

  2. Two Immigrants, One Unique Plan For A Biopharma. This is the story of how the scientific careers of an intrapreneur (Redkar) and an entrepreneur (Yu) came together to cofound and colead Apollomics. HONG KONG, Feb 3, 2021 - (ACN Newswire) - The American Dream is why the United States is considered the "land of opportunity," and why for centuries ...

  3. Space Partnership International LLC of Bethesda, MD, has been engaged to assist NYSH with matters related to the project planning, procurement of satellites and launch services as well as insurance, service development and regulatory activities.

  4. 2022年8月16日 · Gaithersburg, MD, USA and Suzhou BioBay, China, Aug 16, 2022 - (ACN Newswire) - Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced

  5. 2023年9月6日 · 香港, 2023年9月6日 - (亞太商訊) - 香港頂尖的跨界別社企及社創網絡夢創成真 (Dream Impact) 與一直領先業界的優質靈活辦公空間供應商德事商務中心 (TEC) 宣佈共同開設全港首個ESG實體社群空間ESG Innovation Lab,設址位於中環核心地帶的士丹利街28號。. ESG Innovation Lab ...

  6. 2021年2月22日 · Savvy investors in the East are catching up fast with the trend and among them is Black Spade Capital Limited, the family office of casino magnate Lawrence Ho Yau Lung. "We aim to be one of the first Asian family offices to build an SPAC-themed portfolio," said Mr. Dennis Tam, President and CEO of Black Spade Capital.

  7. Sirnaomics Advances GalAhead(TM)-Based RNAi Therapeutics for Treatment of Complement-Related Diseases Gaithersburg, MD, USA and Suzhou BioBay, China, Aug 26, 2022 - (ACN Newswire) - Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today the advancement of its GalAhead(TM) RNAi ...